Fumin Feng
Overview
Explore the profile of Fumin Feng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
241
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu Y, Pei S, Wang X, Li X, Long Y, Sun S, et al.
Mol Biotechnol
. 2024 Dec;
PMID: 39715932
Hepatitis B is a viral infection of the liver caused by the hepatitis B virus (HBV). Entecavir (ETV) is considered the primary therapeutic option for HBV treatment, primarily functioning by...
2.
Pei S, Yang L, Gao H, Liu Y, Dai E, Feng F, et al.
Sci Rep
. 2024 Sep;
14(1):21141.
PMID: 39256598
The escalating frequency of environmental pollution incidents has raised significant concerns regarding the potential health impacts of pollutant fluctuations. Consequently, a comprehensive study on the role of pollutants in the...
3.
Liu T, Wei W, Xu M, Ren Q, Liu M, Pan X, et al.
Microorganisms
. 2024 Jul;
12(7).
PMID: 39065224
(), as a typical intracellular pathogen, possesses several putative restriction-modification (R-M) systems, which restrict exogenous DNA's entry, such as bacterial phage infection. Here, we investigate Rv2528c, a putative Mrr-like type...
4.
Tian F, Li J, Liu Y, Liu W, Liu Y, Xu S, et al.
Emerg Microbes Infect
. 2024 May;
13(1):2361025.
PMID: 38801323
No abstract available.
5.
Chong Y, Li X, Long Y, Pei S, Ren Q, Feng F, et al.
Microbiol Spectr
. 2024 Apr;
12(6):e0393023.
PMID: 38687077
This study aims to elucidate additional mutation loci associated with fluoroquinolone (FQ) resistance and evaluate the discriminatory capacity of mutation loci and allele mutation frequencies in identifying FQ-resistant (MTB) isolates....
6.
Wang L, Meng C, Long Y, Liu Y, Yang L, Gao X, et al.
Int J Biol Macromol
. 2024 Apr;
269(Pt 1):131793.
PMID: 38670193
Anti-tuberculosis drug-induced liver injury (ADLI) is a common adverse reaction during anti-tuberculosis treatment and often leads to treatment interruptions. Circular RNAs (circRNAs) have been identified as key modulators in liver...
7.
Zhang X, Zhan H, Wang L, Liu Y, Guo X, Li C, et al.
Front Med (Lausanne)
. 2024 Feb;
11:1322440.
PMID: 38314204
Objectives: The COVID-19 pandemic imposed an enormous disease and economic burden worldwide. SARS-CoV-2 vaccination is essential to containing the pandemic. People living with HIV (PLWH) may be more vulnerable to...
8.
Tang Q, Meng C, Liu Y, Cheng Y, Liu Y, Long Y, et al.
Int Immunopharmacol
. 2023 Sep;
124(Pt B):110939.
PMID: 37741128
Purpose: The purpose this study is to investigate the impact of SIRT1 on the anti-HBV activity of IFN-α and further elucidate its underlying mechanism. Methods: HepG2.2.15 cells stably transfected with...
9.
Zhang X, Qian C, Yang L, Gao H, Jiang P, Dai M, et al.
PeerJ
. 2023 Jun;
11:e15515.
PMID: 37304882
Background: To date, several types of laboratory tests for coronavirus disease 2019 (COVID-19) diagnosis have been developed. However, the clinical importance of serum severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)...
10.
Hao J, Li Y, Yu Y, Zheng L, Feng F
BMC Microbiol
. 2023 Mar;
23(1):74.
PMID: 36927469
Background: The pathogenesis of anti-tuberculosis (TB) drug-induced liver injury (ADLI) is complicated and remains unclear. We aimed to analyse the relationship between the characteristics of gut microbiota and ADLI in...